Select the type of procedure
21042883
1
Enquiry period
with
06.08.2021 16:22
to 16.08.2021 10:00
to 16.08.2021 10:00
2
Bidding period
with
16.08.2021 10:00
to 21.09.2021 10:30
to 21.09.2021 10:30
3
Auction
will not be used
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
14 622 023,95 MDL
Period of clarifications:
6 Aug 2021, 16:22 - 16 Aug 2021, 10:00
Submission of proposals:
16 Aug 2021, 10:00 - 21 Sep 2021, 10:30
Supplier technical support:
(+373) 79999801
This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.
Subscribe impossible
during the period Evaluation
Achiziţionarea medicamentelor pentru realizarea Programului Naţional de prevenire și control HIV/SIDA și ITS pentru anul 2022
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
6 Aug 2021, 15:36
Date modified
6 Aug 2021, 16:22
Achizitii.md ID
21042883
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 1 - Emtricitabine+Tenofovir disoproxil sau Emtricitabine+Tenofovir disoproxil fumarat 200/245mg sau 200/300mg
Budget: 168248.33 MDL
Purchase has not taken place
Lot nr. 5 - Abacavirum+Lamivudinum 600 mg + 300 mg
Budget: 1639083.54 MDL
Purchase has not taken place
Lot nr. 13 - Benzathini benzylpenicillinum 2400000 UI
Budget: 183862.0 MDL
Purchase has not taken place
Lot nr. 14 - Tenofoviri disoproxili fumaras + Lamivudinum + Efavirenzum 300 mg + 300 mg+ 400 mg
Budget: 394140.36 MDL
Active
Lot nr. 15 - Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg
Budget: 4656253.59 MDL
Active
Lot nr. 18 - Lopinavirum + Ritonavirum 80 mg+20 mg/ml sau 40 mg+10 mg
Budget: 20240.73 MDL
Active
Lot nr. 21 - Tenofoviri alafenamide + Emtricitabinum 25 mg + 200 mg
Budget: 167184.51 MDL
Active
Documents of the procurement procedure
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK